Palbociclib shows promise in patients with hormone-resistant breast cancer
Palbociclib, an investigational oral medication that works by blocking molecules responsible for cancer cell growth, is well tolerated and extends progression-free survival (PFS) in newly diagnosed, advanced breast cancer ...
Feb 20, 2015
0
18